Find Information on a:
View all Postings for:
Search ClotCare
|
Postings on Activated Partial Thromboplastin Time (aPTT)
For Patients and Caregivers
|
Posting
|
Date Posted
|
|
FDA Alert: New USP Standards for Heparin Products Will Result in Decreased Potency
|
October, 2009
|
|
ATryn Available for Patients with Hereditary Antithrombin Deficiency, a Rare Blood Clotting Disorder
|
July, 2009
|
|
Clotting Disorders Presentation by Stephan Moll, MD
|
February, 2007
|
|
New National Performance Measures Issue Mandate to Reduce Incidence of Deep-Vein Thrombosis
|
February, 2007
|
|
New Guidelines to Reduce DVT Risk in Cancer Patients
|
April, 2006
|
|
NIH Conference on Dietary Supplements, Coagulation, and Antithrombotic Therapies
|
March, 2005
|
For Health Care Providers
|
Posting
|
Date Posted
|
|
Subcutaneous Direct Thrombin Inhibitor (Desirudin) Approved for Prevention of DVT in the US; Shown to be Superior to Heparin and Enoxaparin
|
March, 2010
|
|
FDA Alert: New USP Standards for Heparin Products Will Result in Decreased Potency
|
October, 2009
|
|
Changes in Heparin Units, Three ClotCare Editorial Board Members Comment
|
October, 2009
|
|
ATryn Available for Patients with Hereditary Antithrombin Deficiency, a Rare Blood Clotting Disorder
|
July, 2009
|
|
Anticoagulation Safety a Hospital Priority for 2008
|
January, 2008
|
|
New National Performance Measures Issue Mandate to Reduce Incidence of Deep-Vein Thrombosis
|
February, 2007
|
|
Variation in reagent sensitivities confounds use of the aPTT with UFH, DTI, and the combination
|
January, 2007
|
|
Weight-based, fixed-dose, unmonitored subcutaneous UFH administered twice daily found to be equivalent to LMWH for treatment of DVT and PE
|
August, 2006
|
|
Update on Treatment and Prevention of Pulmonary Embolism
|
August, 2006
|
|
Diagnosis, risk-stratification, and management of patients with antiphospholipid antibody syndrome (and/or lupus anticoagulant)
|
July, 2006
|
|
New Guidelines to Reduce DVT Risk in Cancer Patients
|
April, 2006
|
|
New Data Fuels Continued Controversy About Anti-Phospholipid Antibody (APA) and Lupus Anticoagulant Management (LAC)
|
November, 2005
|
|
Anticoagulation Training Programs
|
September, 2005
|
|
NIH Conference on Dietary Supplements, Coagulation, and Antithrombotic Therapies
|
March, 2005
|
|
New Supplement Devoted to Factor Xa Inhibitors (fondaparinux)
|
August, 2004
|
|
Treatment of Deep Vein Thrombosis
|
August, 2004
|
|
New Supplement Devoted to Unfractionated Heparin
|
August, 2004
|
|
Low Molecular Weight Heparin Preferred for Pulmonary Embolism?
|
February, 2004
|
|
Low Molecular Weight Heparin Use Following Prosthetic Valve Surgery Reduces Cost and Length of Stay
|
February, 2004
|
|
|
ClotCare Online Resource covers topics such as Coumadin, warfarin, blood clot, stroke, heart attack, INR, PT, low molecular weight haparin, heparin, dvt, anticoagulation, antithrombotic therapy, A. fib, atrial fibrillation, heart valve, heart valve replacement, vitamin k, AstraZeneca, Aventis, CE credit, and more.
|